Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer

Chinese Journal of Oncology

Volumn 33, Issue 9, 2011, Pages 681-684

  Li, Hua ^a   Zhou, Yi Feng ^b   Guo, Hong Yan ^b   Sun, Tong ^b   Zhang, Wen Hua ^b   Lin, Dong Xin ^b  

^a PEKING UNIVERSITY   (China)

^b NONE

Author keywords

Cervical neoplasms; Cytotoxic T lymphocyte associated antigen 4; Genetic polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ALLELES; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 80155181153     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.09.009     Document Type: Article

References (20)

1. Ferlay JFB, Pisaniand P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2004.
2. Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocr Metab, 1997, 82:4130-4132. (Pubitemid 27525526)
3. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4:336-347. (Pubitemid 38649276)
4. Bekkers RL, Massuger LF, Bulten J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol, 2004, 14:95-105. (Pubitemid 38316009)
5. Guzman VB, Yambartsev A, Goncalves-Primo A, et al. New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet, 2008, 17:1838-1844. (Pubitemid 351791511)
6. Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res, 2008, 68:7025-7034.
7. Cozar JM, Romero JM, Aptsiauri N, et al. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol, 2007, 68:698-704. (Pubitemid 47126657)
8. Ghaderi A, Yeganeh F, Kalantari T, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat, 2004, 86:1-7. (Pubitemid 38918893)
9. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 1995, 270:985-988.
10. Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A, 2003, 100:8372-8377. (Pubitemid 36842552)
11. Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol, 2005, 175:7746-7754. (Pubitemid 41713475)
12. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet, 2001, 29:233-237. (Pubitemid 32952665)
13. Deichmann K, Heinzmann A, Brüggenolte E, et al. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun, 1996, 225:817-818. (Pubitemid 26319188)
14. Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun, 2001, 2:145-152. (Pubitemid 33674879)
15. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 2003, 423:506-511. (Pubitemid 36648570)
16. Pawlak E, Karabon L, Wlodarska-Polinska I, et al. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Hum Immunol, 2010, 71:195-200.
17. Ivansson EL, Juko-Pecirep I, Gyllensten UB. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol, 2010, 116:544-548.
18. Narayan K, McKenzie AF, Hicks RJ, et al. Relation between FIGO stage, primary tumor volume, and presnece of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer, 2003, 13:657-663. (Pubitemid 38222609)
19. Ohno T, Nakayama Y, Nakamoto S, et al. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix. Cancer, 2003, 97:3114-3120. (Pubitemid 36676268)